Seeking Alpha

SciClone Pharmaceuticals (SCLN) announces that results of Phase 2 trials of its cancer treatment...

SciClone Pharmaceuticals (SCLN) announces that results of Phase 2 trials of its cancer treatment SCV-07 didn't meet efficacy endpoints. Shares are currently under a trading halt.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs